Drug
AZD8529 clinical trials
Also written AZD8529.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Development codes
- AZD8529
- 7
Studies by the year they started
7 studies that test it; most in 2009 (3)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 1
AstraZeneca (6) · National Institute on Drug Abuse (NIDA) (1)
Studies
Open first, then newest update. How each study uses AZD8529 is read from its arms, and is right about nine times in ten.
Testing it · 7
- The Study of AZD8529 for Smoking Cessation in Female SmokersCompletedPhase 2National Institute on Drug Abuse (NIDA)NCT02401022Written as AZD8529
- The Effects AZD8529 on Cognition and Negative Symptoms in SchizophrenicsCompletedPhase 1AstraZenecaNCT00986531Written as AZD8529
- The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy VolunteersCompletedEarly Phase 1AstraZenecaNCT00985933Written as AZD8529
- Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia PatientsCompletedPhase 2AstraZenecaNCT00921804Written as AZD 8529
- AZD8529 Single Ascending Dose Study in Healthy Japanese SubjectsCompletedPhase 1AstraZenecaNCT00886756Written as AZD8529
- AZD8529 Multiple Ascending Dose Study in Healthy SubjectsCompletedPhase 1AstraZenecaNCT00765492Written as AZD8529
- AZD8529 Single Ascending Dose StudyCompletedPhase 1AstraZenecaNCT00755378Written as AZD8529
Codes
What other systems call AZD8529 · ClinicalTrials.gg INT000478
- Wikidata Q27074805AZD8529One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27074805 | AZD8529 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.